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Abstract
Background: Internationally, 0.97 per 1,000 live births are affected by foetal alcohol syndrome (FAS). However,
prevalence intelligence has been limited in the UK, hindering the development of appropriate services. This
analysis compares hospital admissions over time, between regions and with alcohol-related admissions for adult
females to assess whether established patterns (such as the North experiencing elevated harms) can be identified.
Methods: A retrospective analysis of hospital admissions data (April 2002 to March 2008) for foetal alcohol
spectrum disorder (FASD)-related conditions: foetal alcohol syndrome (dysmorphic) (n = 457); foetus and newborn
affected by maternal use of alcohol (n = 157); maternal care for (suspected) damage to foetus from alcohol (n =
285); and 322,161 women admitted due to alcohol-related conditions.
Results: Whilst the rate of admission for alcohol-related conditions in women aged 15-44 years increased
significantly by 41% between 2002/03 and 2007/08 (p < 0.0001), no such increases were seen in the numbers of
FASD-related conditions (all p < 0.05). Established regional rates of admission for alcohol-related conditions in
women aged 15-44 years old were not associated with admission for FASD-related conditions.
Conclusions: It would be expected that the North West and North East regions, known to have higher levels of
alcohol harm would have higher levels of FASD-related conditions. However, this was not reflected in the
incidence of such conditions, suggesting under-reporting. With incomplete datasets, intelligence systems are
severely limited, hampering efforts to develop targeted interventions. Improvements to intelligence systems,
practitioner awareness and screening are essential in tackling this.
Background
Worldwide estimates suggest that 0.97 per 1,000 live
births are affected by foetal alcohol syndrome (FAS) [1],
representing a significant cost to health services, with
each affected baby estimated to cost a mean of $2,842
annually [2]. However, long-term costs may be much
higher; FAS is associated with psychiatric problems,
drug and alcohol addiction, memory and attention defi-
cits [3,4], thus affecting a range of services including
criminal justice, education as well as impacting on the
family and local community. In the United Kingdom
(UK), prevalence data are limited. Five UK studies con-
tributed to the worldwide estimate; none identified FAS
b u tt h e yw e r er e s t r i c t e di ns a m p l es i z ea n dg e o g r a p h i c
representation [1,5-10]. Subsequently, an analysis of
Hospital Episode Statistics (HES) reported 128 cases in
2002/03 in England [3]. However, alcohol-related harm
has since escalated [11,12].
Rates of alcohol related hospital admission for alcohol-
related liver disease increased by over 100% between
1989/90 and 2002/03 in England and Wales [12].
Women are particularly at risk of alcohol-related harm
due to biological and social factors [13-15]. For example,
women are more likely to pre-load than men, a beha-
viour associated with higher risk of alcohol-related harm
[15,16]. Such risk factors are of particular importance in
the early stages of pregnancy, when the risks may be
higher (the National Institute for Health and Clinical
Excellence advises abstinence in the first three months)
[17] and women are less likely to be aware of their preg-
nancy status. Levels of consumption are significant in
young women, with one study in North West England
showing that female nightlife users reported an average
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recommended daily maximum of three units [18]. Even
low levels of alcohol consumption, especially if con-
sumed regularly, may affect health. Of women admitted
to hospital for unspecified liver cirrhosis in England in
2005/06, 44.4% were estimated to drink from 0.1 to 2.4
units per day [19]. With no clear guidance on alcohol
consumption in pregnancy and no established dose
related threshold to distinguish between safe and harm-
ful levels of consumption [3,20], pregnant women can
be confused by advice around alcohol consumption [21],
increasing the potential risk for alcohol misuse and the
development of conditions such as FAS. However, with-
out adequate monitoring of prevalence of these condi-
tions, it is no possible to establish the true impact of
consumption on unborn children in the UK.
We explore the reporting on foetal alcohol spectrum
disorder (FASD) related disorder in England using HES.
Hospital admissions were compared over time, between
regions and with alcohol-related hospital admissions for
adult females. We assess whether known geographical
patterns in alcohol related harms (for example, whereby
the North experiences elevated levels of alcohol-attribu-
table hospital admissions and incapacity benefits clai-
mants for alcoholism) [11] are reflected in FAS-related
admission.
Methods
HES is a data warehouse containing details of all admis-
sions to National Health Service (NHS) hospitals in
England, as well as NHS funded inpatient care provided
by independent treatment centres. Each record relates
to an episode of care under a single consultant or medi-
cal team. Up to 20 diagnoses can be recorded for each
episode (increasing from 14 in 2007/08). Diagnoses are
coded using the International Classification of Diseases,
10
th revision (ICD10). We used 4-digit ICD10 codes to
identify inpatient episodes: O35.4, maternal care for
(suspected) damage to foetus from alcohol; P04.3, foetus
and newborn affected by maternal use of alcohol; and
Q86.0, FAS (dysmorphic). Using HES for the UK finan-
cial years (April to March) 2002/03 to 2007/08, we iden-
tified episodes of care where any one of these diagnoses
was recorded. Details extracted included: age at start of
episode; sex; Government Office Region (GOR) of resi-
dence (from nine across England); and person identifier
(HESID). The person identifier is a derived variable that
links episodes of care to the same individual (based on
NHS number and other identifiers), and which can be
used to exclude repeat admissions for the same indivi-
dual. Using the person identifier, we estimated the num-
ber of individuals who were admitted to hospital with
each condition in each financial year. This measure
combines incident and prevalent cases arising in a
12 month period, and allowed us to assess regional and
temporal reporting trends in admission rates which
were free from potential distortions arising from multi-
ple hospital episodes in the same individual.
For admissions for foetus and newborn affected by
maternal use of alcohol (ICD10 P04.3), we calculated
rates using the number of live births in the relevant year
as the denominator [22]. Live births were also used as
the denominator for admission rates for maternal care
for (suspected) damage to foetus from alcohol (O35.4).
For FAS (Q86.0), since a diagnosis is often not made
until later in childhood [3,23], we calculated hospital
admission rates for children aged up to 14 years, and
used mid-year population estimates for children aged up
to 14 years as denominators. Here, we excluded 50 epi-
sodes involving patients aged 15 or over.
In addition, we used HES to estimate the number of
women aged 15-44 years who were admitted to hospital
with an alcohol-related diagnosis from 2002/03 to 2007/
08. The methods used for this are described in detail
elsewhere [19], but involve identifying numbers of indi-
viduals admitted with a range of alcohol-related condi-
tions. For each condition, an alcohol-attributable
fraction (AAF) was applied, which represents the pro-
portion of cases where all alcohol cases are alcohol-
related by definition and the AAF equals 1 (or 100%). It
also includes conditions where alcohol is a contributory
factor in only a proportion of cases, for example road
traffic accidents (AAF: 0.09-0.21 for females aged 15-44
years), and cancers of the lip, oral cavity and pharynx
(AAF: 0.35-0.40). Rates were calculated using mid-year
population estimates for women aged 15-44 years as
denominators. The rates provide a proxy measure of
overall levels of alcohol-related harm in women of child-
bearing age, and can be compared with admission rates
for FASD and related conditions in children.
HES also contains data for NHS outpatient appoint-
ments, and we examined the reporting of FASD-related
conditions here for 2003/04 to 2007/08 [24]. However,
because it is not mandatory for providers to code diag-
noses on outpatient records, the completeness of the
diagnosis fields is very low. Of 54 million outpatient
appointments recorded in 2007/08, less than 3% of out-
patient episodes have a valid diagnosis field [25], and we
therefore predicted that these data would be unsuitable
for assessing regional or temporal trends in FASD-
related conditions. In fact, no cases were identified from
the outpatient records and so no analysis was possible.
Trends in reporting over time and between regions
were assessed using Poisson regression models, with
likelihood ratio tests used to assess temporal and regio-
nal variation. We examined associations between regio-
nal admission rates for FASD-related conditions and
alcohol-related harm in women of childbearing age
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performed using Stata 10. Ethical approval was not
required [26], as secondary analysis of HES data can be
used to identify public health issues and for general
medical research under existing protocols. All analyses
performed complied with these regulations [27].
Results
Between 2002/03 and 2007/08, there were 987 episodes
with a diagnosis of FAS (ICD10 code Q86.0) involving
457 children aged under 15 years (Tables 1 and 2).
Around 36% of children were aged under 1 at the time
of admission (Table 2). The number of persons admitted
increased substantially in 2006/07, relative to earlier
years, and remained high in 2007/08. The overall trend
was highly significant (p = 0.0001). Table 3 shows there
were significant variations in regional rates (p <0 . 0 0 0 1
for heterogeneity). The North West had the highest rate
of admissions at 1.67 (95%CIs: 1.39-1.99) per 100,000
population, while the lowest rates were seen in the
North East (0.41 per 100,000; 95%CIs: 0.21-0.74).
There were 356 episodes with a diagnosis of foetus
and newborn affected by maternal use of alcohol
(ICD10: P04.3) between 2002/03 and 2007/08, involving
285 individuals (Tables 1 and 2). Nearly all (99%) were
aged under one year when admitted (Table 2). The
number of persons admitted increased by 59%, from 32
in 2002/03 to 51 in 2007/08, but this trend was not sta-
tistically significant (p = 0.22). The rate of admissions
varied significantly (p = 0.025) between regions, ranging
from 1.8 per 100,000 live births in London (95%CIs: 0.4-
5.2) to 5.8 per 100,000 live births in the East Midlands
(95%CIs: 3.4-9.3; Table 3). However, the region of resi-
dence was missing for 47% of the patients, so that the
overall rate for England was higher than any of the
regional rates at 7.8 per 100,000 live births (95%CIs: 6.9-
8.7).
There were 184 episodes of maternal care for (sus-
pected) damage to the foetus from alcohol (ICD10:
O35.4) in England, involving 157 individuals (Tables 1
and 2). A quarter were women aged 15-24 years and the
remainder were over 24 years. The number of persons
admitted between 2002/03 and 2007/08 increased by
63% from 19 in 2002/03 to 31 in 2007/08 but the overall
trend was not statistically significant (p = 0.16). There
was significant regional variation in rates (p = 0.0001),
ranging from 1.7 per 100,000 live births in London (95%
CIs: 0.9-3.0) to 7.2 in the East Midlands and South
West (Table 3).
Admission rates for alcohol related conditions in
women aged 15-44 increased by 41% between 2002/03
and 2007/08 from 418 to 591 per 100,000. This increase
was highly significant (p < 0.0001). Admission rates ran-
ged from 757 [747-767] per 100,000 women aged 15-44
years in the North East regions to 375 [372-379] per
100,000 in London (Table 3). There was no significant
correlation between the regional admission rates for
alcohol-related harm in women and admissions for the
three alcohol-related diagnoses involving children or
pregnant women.
Discussion
It is extremely difficult to accurately estimate the preva-
lence of disorders such as FASD. There is uncertainty as
to the level of maternal alcohol consumption that can
c a u s eF A S D - r e l a t e dd a m a g e[ 4 ] ,a n di tc a nb ed i f f i c u l t
to obtain a valid understanding of consumption during
pregnancy [28] as alcohol consumption amongst preg-
nant women is a highly sensitive area. In fact, experts in
the United States of America suggest that the stigma
Table 1 Trends in Hospital Episode Statistics for foetal alcohol spectrum disorder and related conditions, in residents
of England 2002/03 to 2007/08
Q86.0: Foetal alcohol syndrome
(dysmorphic), children aged under 15
years
P04.3: Foetus and newborn affected
by maternal use of alcohol
O35.4: Maternal care for (suspected)
damage to foetus from alcohol
Financial year** Persons (episodes)* Persons (episodes)* Persons (episodes)*
n trend*** n trend*** n trend***
2002/03 71 (114) Χ2(1 d.f.) = 15.48 32 (43) Χ2 (1 d.f.) = 1.52 19 (21) Χ2 (1 d.f.) = 1.95
2003/04 50 (84) p = 0.0001 40 (42) p = 0.22 19 (23) p = 0.16
2004/05 69 (178) 55 (64) 29 (37)
2005/06 73 (142) 62 (88) 33 (41)
2006/07 96 (197) 45 (56) 26 (28)
2007/08 98 (272) 51 (63) 31 (34)
Total 457 (987) 285 (356) 157 (184)
* The Hospital Episodes Statistics identification (HESID) field was used to link episodes relating to the same individual within a given year.
** The UK financial year runs from April to March.
*** A test of linear trend was obtained using likelihood ratio tests from Poisson regression models for rates based on number of individuals admitted.
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Page 3 of 6Table 2 Hospital Episode Statistics for foetal alcohol spectrum disorder and related conditions, in residents of England
2002/03 to 2007/08 by person admitted*
Patient characteristic Q86.0: Foetal alcohol syndrome
(dysmorphic), children aged under
15 years
P04.3: Foetus and newborn
affected by maternal use of
alcohol
O35.4: Maternal care for (suspected)
damage to foetus from alcohol
n% n % n %
Age group
<1 month 104 22.8 278 97.5 0 0
2-11 months 62 13.6 4 1.4 0 0
1-4 years 155 33.9 1 0.4 0 0
5-14 years 136 29.8 0 0.0 0 0
15-24 years N/A 0 0.0 39 24.8
25-44 years N/A 1 0.4 118 75.2
Not known 1 0.4
Sex
Male 235 51.4 145 50.9 N/A N/A
Female 222 48.6 139 48.8 157 100
Not known 1 0.4
Total** 457 100 285 100 157 100
*The Hospital Episodes Statistics identification (HESID) field was used to exclude repeat episodes relating to the same individual within a given financial year
(running April to March). **Percentages may not sum to 100% due to rounding.
Table 3 Reporting rates for foetal alcohol spectrum disorder and related conditions, and hospital admission rates for
alcohol related conditions in women aged 15-44 years, England 2002/03 to 2007/08 (by person admitted*)
Government Office region of residence Q86.0: Foetal alcohol
syndrome (dysmorphic),
children aged under 15
years
P04.3: Foetus and
newborn affected
by maternal use of
alcohol
O35.4: Maternal care
for (suspected)
damage to foetus
from alcohol
Women aged 15-44 years,
admitted to hospital with
alcohol related
conditions**
n Rate per 100,000
pop (95%CI)
n Rate per
100,000 live
births (95%
CI)
n Rate per
100,000 live
births (95%CI)
n Rate per
100,000 pop
(95%CI)
North East 11 0.41 (0.21-0.74) 3 1.8 (0.4-5.2) 4 2.4 (0.6-6.1) 23,561 757 (747-767)
North West 125 1.67 (1.39-1.99) 21 4.3 (2.7-6.6) 18 3.7 (2.2-5.9) 59,963 715 (709-721)
Yorkshire and Humber 30 0.54 (0.37-0.77) 19 5.3 (3.2-8.2) 12 3.3 (1.7-5.8) 35,990 571 (566-577)
East Midlands 32 0.69 (0.47-0.98) 17 5.8 (3.4-9.3) 21 7.2 (4.4-11) 27,029 516 (510-522)
West Midlands 32 0.54 (0.37-0.76) 9 2.3 (1.0-4.3) 25 6.3 (4.1-9.4) 34,186 529 (523-534)
East of England 46 0.76 (0.56-1.01) 20 5.2 (3.1-8.0) 11 2.8 (1.4-5.1) 26,637 402 (397-407)
London 68 0.83 (0.65-1.06) 17 2.5 (1.4-3.9) 12 1.7 (0.9-3.0) 40,894 375 (372-379)
South East 41 0.46 (0.33-0.63) 27 4.8 (3.1-6.9) 30 5.3 (3.6-7.5) 42,612 431 (427-435)
South West 31 0.60 (0.41-0.85) 17 5.4 (3.1-8.6) 23 7.2 (4.6-10.9) 29,840 517 (511-522)
England*** 457 0.84 (0.76-0.92) 285 7.8 (6.9-8.7) 157 4.3 (3.6-5.0) 322,161 514 (512-516)
Correlation coefficient (p-value)**** 0.26 (0.50) -0.26 (0.50) -0.08 (0.83) –
Test for heterogeneity Χ
2(8 d.f.) = 88.62,
p < 0.0001
Χ
2(8 d.f.) = 17.56,
p = 0.025
Χ
2(8 d.f.) = 33.43,
p = 0.0001
Χ
2(8 d.f.) = 17044,
p < 0.0001
*The Hospital Episodes Statistics identification (HESID) field was used to link episodes relating to the same individual within a given HES year (running April to
March). Percentages may not sum to 100% due to rounding. ** See Jones et al. (2008) for details of attributable fractions applied. *** Figures for England include
reports where region of residence was not recorded, and so the numbers provided are not the sum of the regional numbers. ****Pearson’s correlation co-
efficient was used to assess correlations between the prevalence of alcohol related hospital admission (for women aged 15-44) and FAS or related conditions
across regions.
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of a diagnosis [28]. However, even without any asso-
ciated stigma, diagnosis is difficult, not only due to the
specialist training required [28,29] but also because
affected individuals may have other diagnosable disor-
ders or secondary disabilities [29], making it difficult to
isolate FASD. Passive surveillance systems, such as HES
used in this analysis, also present limitations. Intelli-
gence may be restricted because systems rely on correct
diagnosis by a large number of different medical practi-
tioners [30]. Furthermore, trends in hospital data may
be influenced by differential access and changes in ser-
vice provision [31], as well as relying on individuals to
have a reason to require hospital admission.
The HES data show an overall rate of hospital admis-
sion for FAS to be 0.84 per 100,000 population in
England from 2002/03 to 2007/08. However, such fig-
ures cannot be used to measure prevalence as they can
only capture intelligence on individuals admitted to hos-
pital within a given year. Thus, other data collection
methods (including clinical and epidemiological studies)
produce higher incidence estimates, with worldwide esti-
m a t e sf o rF A Sa t0 . 9 7p e r1 , 0 0 0[ 1 ] ,a n dm o r er e c e n t
estimates for Lazio (Italy) and mixed-racial, mixed
socioeconomic populations in the United States of
America at up to 7 per 1,000 [32,33]. Nevertheless, our
findings highlight the limitations of current recording of
FAS and FASD in England, and support the need for
further development of the dataset if appropriate ser-
vices are to be developed. Whilst the levels of alcohol-
related harm including attributable hospital admission,
mortality and crime have been increasing in recent years
[11], no such increases were seen in any of the three
diagnoses discussed here: FAS (Q86.0), maternal care
for (suspected) damage to the foetus from alcohol
(ICD10: O35.4) or foetus and newborn were affected by
maternal use of alcohol. Because of the wide age range
for children admitted with FAS (Q86.0), interpretation
of temporal trends are more complicated for this condi-
tion. This is because to some extent the admissions will
reflect maternal alcohol consumption patterns up to 15
years earlier, and for which we have no data. We found
no evidence of an increase in admissions for FAS
among children aged under 1 year, although numbers
were admittedly very small, during a period when
admissions for alcohol related harms in women of child-
bearing age increased quite substantially.
We would predict that regional variations in alcohol-
related hospital admissions in women of child-bearing
age would be related to FASD diagnoses. Thus, it would
be expected that the North West and North East
regions, known to have higher levels of alcohol misuse
and harm (evidenced by hospital admission data pre-
sented here as well as other harms including incapacity
benefits claimants for alcoholism) [11] would have
higher levels of FASD-related conditions. This was not
f o u n dt ob et h ec a s e ,s t r o n g l ys u g g e s t i n gu n d e r - r e p o r t -
ing of FASD-related conditions. The argument for
under-reporting was strengthened through the outpati-
ent data examined, where no episodes were revealed
between 2003/04 and 2007/08 even though children
with FASD-related conditions receive treatment as out-
patients [3]. However routine outpatient dataset for
England cannot provide any intelligence on this at pre-
sent. Whereas treatment specialty is a mandatory
reporting item for outpatient episodes, diagnosis and
procedure codes are not [25]. As long as this remains
the case, hospitals have little incentive to spend time
and resources on reporting them, and hence the infor-
mation is missing for the majority of records.
To understand the full extent of underreporting, an
active ascertainment study is required [29]. The use of
alcohol pregnancy screening tools (such as TACE or
TWEAK) to identify high risk pregnancies is crucial
here [3], although their validation in a UK setting is
required. Screening could be performed by nurses, mid-
wives and/or general practitioners, all of whom pregnant
women are likely to encounter during their pregnancy.
However, exposure to alcohol does not appear to have a
direct correlation to outcome [4]. This means that,
other than the most extreme cases, risk can be ascribed
at birth or during pregnancy but it is not possible to
provide a firm diagnosis. This is because difficulties
often do not arise until later in life [3]. Without ade-
quate screening or recording, if diagnosis cannot be
made until later in life, complications can arise if crucial
information has been lost, forgotten or become unavail-
able. To help address these issues, neonatal discharge
summaries could include a section on high risk factors
for later disorders including maternal alcohol consump-
tion. This would follow the child and be accessible to
them in later life, should such a diagnosis be sought.
Finally the methods used to diagnose FASD are not con-
sistent and there appears to be a lack of awareness as to
the correct diagnostic framework. This could be
addressed through improved training and more consis-
tent use of diagnosis tools (such as the four digit code
[3]) by community paediatricians, the most likely profes-
sionals to which these children will present to for
diagnosis.
Conclusions
Current intelligence surrounding FASD-related disorders
in England is severely limited. Data provided in this
report serve to underline the existing gaps rather than
present an understanding of the situation. If FASD-
related disorders are to be effectively prevented, identi-
fied and treated, improvements to intelligence systems,
Morleo et al. BMC Pediatrics 2011, 11:14
http://www.biomedcentral.com/1471-2431/11/14
Page 5 of 6practitioner awareness and screening are essential. It is
only by understanding incidence and characteristics of
at-risk groups that effective services and interventions
can be developed.
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